CLINICOPATHOLOGICAL HETEROGENEITY IN HYPERTROPHIC CARDIOMYOPATHY WITHREGARD TO AGE, ASYMMETRIC SEPTAL HYPERTROPHY, AND CONCENTRIC HYPERTROPHY BEYOND THE PEDIATRIC AGE GROUP
Sh. Litovsky et Ag. Rose, CLINICOPATHOLOGICAL HETEROGENEITY IN HYPERTROPHIC CARDIOMYOPATHY WITHREGARD TO AGE, ASYMMETRIC SEPTAL HYPERTROPHY, AND CONCENTRIC HYPERTROPHY BEYOND THE PEDIATRIC AGE GROUP, Archives of pathology and laboratory medicine, 122(5), 1998, pp. 434-441
Citations number
35
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
Background.-To our knowledge, no histopathologic study of the differen
ces between hypertrophic cardiomyopathy in different age groups or tha
t contrasts the pathologic findings in the asymmetric septal hypertrop
hy and concentric hypertrophy forms of hypertrophic cardiomyopathy has
been published. Methods.-The clinicopathologic findings of younger (l
ess than or equal to 60 years) (n = 35) and older (>60 years) (n = 20)
patients with hypertrophic cardiomyopathy were assessed. Each group w
as subdivided into groups of patients with asymmetric septal hypertrop
hy or concentric hypertrophy. Results.-Among the young patients, asymm
etric septal hypertrophy was more prevalent than concentric hypertroph
y, whereas among the elderly patients, concentric hypertrophy was more
common. Sudden death was prevalent only among the young. Most young p
atients had a mirror-image endocardial fibrous septal plaque, whereas
most elderly patients with concentric hypertrophy did not. Ventricular
septal myocyte disarray and intramural coronary artery thickening wer
e far more marked among the young with asymmetric septal hypertrophy t
han the young with concentric hypertrophy and the elderly. Conclusions
.-Key differences exist between younger and older patients with hypert
rophic cardiomyopathy. Much higher degrees of ventricular disarray and
intramural coronary artery disease were noted in younger patients wit
h asymmetric septal hypertrophy compared to the elderly patients and t
he younger patients with concentric hypertrophy.